Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Immunology Research|July 12, 2018
Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLCFernando C Santini, Hira Rizvi, Andrew J Plodkowski, et al.
JTO Clinical and Research Reports|July 21, 2025
A Phase II Study of Cabozantinib in Patients With MET-Altered Lung CancersGuilherme Harada, Fernando C Santini, Clare J Wilhelm, et al.
Future Oncology (London, England)|November 5, 2020
Phase III study of selpercatinib versus chemotherapy ± pembrolizumab in untreated RET positive non-small-cell lung cancerBenjamin J Solomon, Cai Cun Zhou, Alexander Drilon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung CancerNoura J Choudhury, W Victoria Lai, Alex Makhnin, et al.
The New England Journal of Medicine|October 23, 2023
First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLCCaicun Zhou, Benjamin Solomon, Herbert H Loong, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancerSi-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Pageof 2